Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Treated with Neoadjuvant Chemotherapy”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Testing effectiveness (Phase 2)Looking for participantsNCT04329065
What this trial is testing

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
University of Washington 25
Testing effectiveness (Phase 2)UnknownNCT05400993
What this trial is testing

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Who this might be right for
Breast Cancer
Shengjing Hospital 59
Testing effectiveness (Phase 2)Study completedNCT03188393
What this trial is testing

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Who this might be right for
Invasive Breast CarcinomaStage II Breast CancerStage IIA Breast Cancer+2 more
NRG Oncology 105
Large-scale testing (Phase 3)Active Not RecruitingNCT03595592
What this trial is testing

Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

Who this might be right for
Invasive Breast Cancer
Fondazione Michelangelo 650
Testing effectiveness (Phase 2)Ended earlyNCT02795572
What this trial is testing

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Who this might be right for
Peripheral Neuropathy in Breast Cancer Patient
AHS Cancer Control Alberta 13
Large-scale testing (Phase 3)Study completedNCT00512993
What this trial is testing

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 654
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Not applicableWithdrawnNCT00934401
What this trial is testing

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
University of Iowa
Post-approval studies (Phase 4)UnknownNCT05036005
What this trial is testing

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

Who this might be right for
Breast CancerBreast NeoplasmsBreast Cancer Female+1 more
Institut fuer Frauengesundheit 108
Testing effectiveness (Phase 2)Study completedNCT00194779
What this trial is testing

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast Cancer+6 more
University of Washington 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02445391
What this trial is testing

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+9 more
ECOG-ACRIN Cancer Research Group 415
Large-scale testing (Phase 3)Study completedNCT00513292
What this trial is testing

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

Who this might be right for
HER2/Neu PositiveStage IA Breast CancerStage IB Breast Cancer+2 more
National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Study completedNCT00128856
What this trial is testing

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 46
Not applicableStudy completedNCT04440930
What this trial is testing

White Tea for Prevention of Chemotherapy Induced Mucositis

Who this might be right for
Oral Mucositis
Vejle Hospital 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT02883062
What this trial is testing

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7Stage III Breast Cancer AJCC v7+1 more
National Cancer Institute (NCI) 67
Testing effectiveness (Phase 2)Study completedNCT01203267
What this trial is testing

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT01750073
What this trial is testing

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+13 more
University of Nebraska 92
Testing effectiveness (Phase 2)Study completedNCT03248427
What this trial is testing

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 106
Testing effectiveness (Phase 2)WithdrawnNCT02053597
What this trial is testing

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen

Who this might be right for
Breast Cancer
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT00194792
What this trial is testing

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+3 more
University of Washington 28
Load More Results